SRF is a nuclear repressor of Smad3-mediated TGF-β signaling

被引:0
|
作者
H-J Lee
C-H Yun
S H Lim
B-C Kim
K G Baik
J-M Kim
W-H Kim
S-J Kim
机构
[1] Laboratory of Cell Regulation and Carcinogenesis,Division of Molecular Therapeutics
[2] National Cancer Institute,Department of Biological Sciences
[3] Korea Research Institute of Bioscience and Biotechnology (KRIBB),Division of Life Sciences
[4] Korea Advanced Institute of Science and Technology,Dr Department of Pathology
[5] Kangwon National University,undefined
[6] Cancer Research Institute,undefined
[7] Seoul National University College of Medicine,undefined
[8] Inha University College of Medicine,undefined
来源
Oncogene | 2007年 / 26卷
关键词
SRF; TGF-; Smad; signaling; transcription; suppression;
D O I
暂无
中图分类号
学科分类号
摘要
Serum response factor (SRF) is a widely expressed transcription factor involved in immediate-early and tissue-specific gene expression, cell proliferation and differentiation. We defined a new role of SRF as a nuclear repressor of the tumor growth factor β1 (TGF-β1) growth-inhibitory signal during cell proliferation. We show that SRF significantly inhibits the TGF-β1/Smad-dependent transcription by associating with Smad3. SRF causes resistance to the TGF-β1 cytostatic response by directly repressing the Smad transcriptional activity and Smad binding to DNA. Furthermore, we demonstrated that overexpression of SRF markedly decreases the level of Smad3 complex binding to the promoters of Smad3 target genes, p15INK4b and p21Cip1. This leads to the inhibition of expression of TGF-β1-responsive genes. SRF therefore acts as a nuclear repressor of Smad3-mediated TGF-β1 signaling.
引用
收藏
页码:173 / 185
页数:12
相关论文
共 50 条
  • [31] TGF-β/Smad signaling in the injured liver
    Breitkopf, K
    Godoy, P
    Ciuclan, L
    Singer, MV
    Dooley, S
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2006, 44 (01): : 57 - 66
  • [32] TGF-β/Smad Signaling in Kidney Disease
    Lan, Hui Y.
    Chung, Arthur C. -K.
    SEMINARS IN NEPHROLOGY, 2012, 32 (03) : 236 - 243
  • [33] TGF-β/Smad signaling in renal fibrosis
    Meng, Xiao-Ming
    Tang, Patrick Ming-Kuen
    Li, Jun
    Lan, Hui Yao
    FRONTIERS IN PHYSIOLOGY, 2015, 6
  • [34] TGF-β/Smad signaling in prostate cancer
    Bello-DeOcampo, D
    Tindall, DJ
    CURRENT DRUG TARGETS, 2003, 4 (03) : 197 - 207
  • [35] Roles of Smad3 in TGF-β signaling during carcinogenesis
    Millet, Caroline
    Zhang, Ying E.
    CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 2007, 17 (04): : 281 - 293
  • [36] A dual role of TGF-β in human osteoclast differentiation mediated by Smad1 versus Smad3 signaling
    Lee, Bitnara
    Oh, Younseo
    Jo, Sungsin
    Kim, Tae-Hwan
    Ji, Jong Dae
    IMMUNOLOGY LETTERS, 2019, 206 : 33 - 40
  • [37] Mechanisms of action of TGF-β in cancer -: Evidence for Smad3 as a repressor of the hTERT gene
    Li, He
    Liu, Jun-Ping
    HEALTHY AGING AND LONGEVITY, 2007, 1114 : 56 - 68
  • [38] Smad3-mediated lncRNA HSALR1 enhances the non-classic signaling pathway of TGF-ß1 in HBFs by binding to HSP90AB1
    Yi, Erakng
    Ran, Pixin
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [39] TGF-β/Smad Signaling Pathway in Tubulointerstitial Fibrosis
    Yu, Xiao-Yong
    Sun, Qian
    Zhang, Ya-Mei
    Zou, Liang
    Zhao, Ying-Yong
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [40] Intracellular signaling of the TGF-β superfamily by Smad proteins
    Kawabata, M
    Imamura, T
    Inoue, H
    Hanai, JI
    Nishihara, A
    Hanyu, A
    Takase, M
    Ishidou, Y
    Udagawa, Y
    Oeda, E
    Goto, D
    Yagi, K
    Kato, M
    Miyazono, K
    ANTICANCER MOLECULES: STRUCTURE, FUNCTION, AND DESIGN, 1999, 886 : 73 - 82